Spondylodiscitis
12
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Evaluation of Outcomes of Surgical Treatment for Nonspecific Infectious Spondylodiscitis Via Posterior Approach in One Center.
Spondylodiscitis: a Retrospective Observational Study.
Paper-based Electrochemical Point-of-care Device in Diagnostic of Orthopedic Infections
Gene Expression Profiles in Spinal Tuberculosis.
Spondylodiscitis Cases at Assiut University Hospital
Spine Registry University Hospital of Cologne- Department of Orthopedics
CORset Versus OstéoSynthese in Adult Pyogenic Spondylodiscitis
Follow up Patients With Thoracolumbar Spondylodiscitis Surgically Treated by Posterior Approach
Immobilization and Neurological Complications in Patients With Vertebral Osteomyelitis.
Conservative Versus Surgical Treatment of Native Vertebral Osteomyelitis
Cytokine Profiles and suPAR in Spondylodiscitis
The Value of PET/CT in Diagnosing Residual Disease in Patients With Spinal Infection